Diabetes Drug Mounjaro Approved For Weight Loss Treatment in Britain

Mounjaro (tirzepatide) still requires further approvals for use in the NHS, but has been described to have the potential to help people living with obesity.
Diabetes Drug Mounjaro Approved For Weight Loss Treatment in Britain
Mohammed_Al_Ali/Shutterstock
|Updated:
0:00
A diabetes drug Mounjaro (tirzepatide), has been approved by an executive medicines regulator to treat obesity in adults aged 18 and over.

The Medicines and Healthcare products Regulatory Agency (MHRA) authorized the use of Mounjaro for weight management and weight loss. Patients, who take the medicine, are supposed to follow a reduced-calorie diet and exercise actively.

Evgenia Filimianova
Evgenia Filimianova
Author
Evgenia Filimianova is a UK-based journalist covering a wide range of national stories, with a particular interest in UK politics, parliamentary proceedings and socioeconomic issues.
Related Topics